{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:45:27Z","timestamp":1782593127882,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04458-7","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:36:03Z","timestamp":1782585363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived organoids in gynaecological cancers: emerging tools for therapy and disease modelling"],"prefix":"10.1007","author":[{"given":"Naveen","family":"Vigneshwaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamizhanban","family":"Thangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-800X","authenticated-orcid":false,"given":"Krupakar","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatanarayanan","family":"Haribalaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"4458_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40164-025-00684-x","volume":"14","author":"T Pan","year":"2025","unstructured":"Pan T, Zhang J, Wang X, Song Y. Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021. Exp Hematol Oncol. 2025;14(1):98.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"4458_CR2","first-page":"120","volume":"73","author":"TB Kratzer","year":"2023","unstructured":"Kratzer TB, Jemal A, Miller KD, Nash S, Wiggins C, Redwood D et al. Cancer statistics for A merican I ndian and A laska N ative individuals, 2022: Including increasing disparities in early onset colorectal cancer. CA: A Cancer Journal for Clinicians. 2023 Mar;73(2):120-46.","journal-title":"J Clin"},{"issue":"7353","key":"4458_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"CGAR","year":"2011","unstructured":"CGAR. Network, Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609.","journal-title":"Nature"},{"issue":"9","key":"4458_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41571-018-0055-6","volume":"15","author":"A Ashworth","year":"2018","unstructured":"Ashworth A, Lord CJ. Synthetic lethal therapies for cancer: what\u2019s next after PARP inhibitors? Nat Re Clin Oncol. 2018;15(9):564\u201376.","journal-title":"Nat Re Clin Oncol"},{"key":"4458_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2022.902371","volume":"3","author":"K Ellis","year":"2022","unstructured":"Ellis K, Munro D, Clarke J. Endometriosis is undervalued: a call to action. Front Glob Womens Health. 2022;3:902371.","journal-title":"Front Glob Womens Health"},{"issue":"1","key":"4458_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5301\/je.5000270","volume":"9","author":"C Tosti","year":"2017","unstructured":"Tosti C, Vannuccini S, Tro\u00eca L, Luisi S, Centini G, Lazzeri L et al. Long-term vaginal danazol treatment in fertile age women with adenomyosis. Journal of Endometriosis and Pelvic Pain Disorders. 2017 Jan;9(1):39-43.","journal-title":"J Endometr Pelvic Pain Disord"},{"issue":"3","key":"4458_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","volume":"29","author":"GAJ Dunselman","year":"2014","unstructured":"Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B et al. ESHRE guideline: management of women with endometriosis. Human reproduction. 2014 Mar 1;29(3):400-12.","journal-title":"Hum Reprod"},{"issue":"7","key":"4458_CR8","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modelling development and disease with organoids. Cell. 2016;165(7):1586\u201397.","journal-title":"Cell"},{"issue":"7735","key":"4458_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41586-018-0753-3","volume":"564","author":"MY Turco","year":"2018","unstructured":"Turco MY, Gardner L, Kay RG, Hamilton RS, Prater M, Hollinshead MS et al. Trophoblast organoids as a model for maternal\u2013fetal interactions during human placentation. Nature. 2018 Dec;564(7735):263-7.","journal-title":"Nature"},{"issue":"10","key":"4458_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1242\/dev.148478","volume":"144","author":"M Boretto","year":"2017","unstructured":"Boretto M, Cox B, Noben M, Hendriks N, Fassbender A, Roose Het al. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development. 2017 May 15;144(10):1775-86.","journal-title":"Development"},{"issue":"1","key":"4458_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, De Ligt J, Kopper O, Gogola E, Bounova G, Weeber F et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018 Jan 11;172(1):373-86.","journal-title":"Cell"},{"issue":"R2","key":"4458_CR12","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1093\/hmg\/ddy187","volume":"27","author":"B Artegiani","year":"2018","unstructured":"Artegiani B, Clevers H. Use and application of 3D-organoid technology. Hum Mol Genet. 2018;27(R2):R99\u2013107.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4458_CR13","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41467-019-11091-2","volume":"10","author":"S-J Park","year":"2019","unstructured":"Park SJ, Kim RY, Park BW, Lee S, Choi SW, Park JH et al. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nature communications. 2019 Jul 16;10(1):3123.","journal-title":"Nat Commun"},{"key":"4458_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gde.2015.02.007","volume":"30","author":"D Gao","year":"2015","unstructured":"Gao D, Chen Y. Organoid development in cancer genome discovery. Curr Opin Genet Dev. 2015;30:42\u20138.","journal-title":"Curr Opin Genet Dev"},{"issue":"11","key":"4458_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, Aspuria PJ, Bast Jr RC, Beral V et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nature reviews Cancer. 2015 Nov;15(11):668-79.","journal-title":"Nat Rev Cancer"},{"issue":"7447","key":"4458_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"DA Levine","year":"2013","unstructured":"Levine, Douglas A., et al. \"Integrated genomic characterization of endometrial carcinoma.\" Nature 497.7447 (2013): 67-73.","journal-title":"Nature"},{"key":"4458_CR17","doi-asserted-by":"crossref","unstructured":"Zondervan KT, Becker CM, Kago K, Missmer SA, Taylor RN, and Vigano P, Endometriosis. Nat Rev Dis Primers 2018; 4","DOI":"10.1038\/s41572-018-0008-5"},{"issue":"6194","key":"4458_CR18","first-page":"1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science (1979). 2014;345(6194):1247125.","journal-title":"Science (1979)"},{"issue":"11","key":"4458_CR19","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","volume":"8","author":"SJ Hill","year":"2018","unstructured":"Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG, Worley Jr MJ et al. Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids. Cancer discovery. 2018 Nov 1;8(11):1404-21.","journal-title":"Cancer Discov"},{"issue":"8","key":"4458_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","volume":"21","author":"M Boretto","year":"2019","unstructured":"Boretto M, Maenhoudt N, Luo X, Hennes A, Boeckx B, Bui B et al. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nature cell biology. 2019 Aug;21(8):1041-51.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"4458_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper O, De Witte CJ, L\u00f5hmussaar K, Valle-Inclan JE, Hami N, Kester L et al. An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity. Nature medicine. 2019 May;25(5):838-49.","journal-title":"Nat Med"},{"issue":"5","key":"4458_CR22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer discovery. 2017 May 1;7(5):462-77.","journal-title":"Cancer Discov"},{"issue":"5","key":"4458_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/jpm12050695","volume":"12","author":"T Kiwaki","year":"2022","unstructured":"Kiwaki T, Kataoka H. Patient-derived organoids of colorectal cancer: a useful tool for personalized medicine. J Pers Med. 2022;12(5):695.","journal-title":"J Pers Med"},{"issue":"4","key":"4458_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmgh.2017.12.010","volume":"5","author":"A Bein","year":"2018","unstructured":"Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A et al. Microfluidic organ-on-a-chip models of human intestine. Cellular and molecular gastroenterology and hepatology. 2018 Jan 1;5(4):659-68.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"4458_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","volume":"22","author":"B Artegiani","year":"2020","unstructured":"Artegiani B, Hendriks D, Beumer J, Kok R, Zheng X, Joore I at al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR\u2013Cas9 precision genome editing. Nature cell biology. 2020 Mar;22(3):321-31.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4458_CR26","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","volume":"10","author":"Y Nanki","year":"2020","unstructured":"Nanki Y, Chiyoda T, Hirasawa A, Ookubo A, Itoh M, Ueno M et al. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing. Scientific reports. 2020 Jul 28;10(1):12581.","journal-title":"Sci Rep"},{"issue":"1","key":"4458_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s13046-021-02139-7","volume":"40","author":"M Tao","year":"2021","unstructured":"Tao M, Wu X. The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing. J Exp Clin Cancer Res. 2021;40(1):338.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"4458_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41591-022-01746-x","volume":"28","author":"RC Fitzgerald","year":"2022","unstructured":"Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N. The future of early cancer detection. Nat Med. 2022;28(4):666\u201377.","journal-title":"Nat Med"},{"issue":"1","key":"4458_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.rbmo.2022.03.016","volume":"45","author":"F Esfandiari","year":"2022","unstructured":"Esfandiari F, Mansouri N, Shahhoseini M, Khoei HH, Mikaeeli G et al. Endometriosis organoids: prospects and challenges. Reproductive BioMedicine Online. 2022 Jul 1;45(1):5-9.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"4458_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ncb3516","volume":"19","author":"MY Turco","year":"2017","unstructured":"Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L et al. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nature cell biology. 2017 May;19(5):568-77.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4458_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/jpm12020219","volume":"12","author":"E Ju\u00e1rez-Barber","year":"2022","unstructured":"Ju\u00e1rez-Barber E, Franc\u00e9s-Herrero E, Corach\u00e1n A, Vidal C, Giles J, Alam\u00e1 P et al. Establishment of adenomyosis organoids as a preclinical model to study infertility. Journal of Personalized Medicine. 2022 Feb 4;12(2):219.","journal-title":"J Pers Med"},{"key":"4458_CR32","doi-asserted-by":"publisher","first-page":"096368972311879","DOI":"10.1177\/09636897231187996","volume":"32","author":"Q Cao","year":"2023","unstructured":"Cao Q, Li L, Zhao Y, Wang C, Shi Y, Tao X et al. PARPi decreased primary ovarian cancer organoid growth through early apoptosis and base excision repair pathway. Cell transplantation. 2023 Jul;32:09636897231187996.","journal-title":"Cell Transplant"},{"issue":"1","key":"4458_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13048-024-01520-2","volume":"17","author":"L-Y Chen","year":"2024","unstructured":"Chen LY, Chou YT, Liew PL, Chu LH, Wen KC, Lin SF et al. In vitro drug testing using patient-derived ovarian cancer organoids. Journal of Ovarian Research. 2024 Dec 5;17:243.","journal-title":"J Ovarian Res"},{"issue":"10","key":"4458_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo B-K, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020;21(10):571\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4458_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12072-021-10237-z","volume":"15","author":"G Ramakrishna","year":"2021","unstructured":"Ramakrishna G, Babu PE, Singh R, Trehanpati N. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids. Hepatol Int. 2021;15(6):1309\u201317.","journal-title":"Hepatol Int"},{"issue":"8","key":"4458_CR36","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.18632\/aging.204023","volume":"14","author":"Z Xu","year":"2022","unstructured":"Xu Z, Song J, Cao L, Rong Z, Zhang W, He J et al. Improving ovarian cancer treatment decision using a novel risk predictive tool. Aging (Albany NY). 2022 Apr 19;14(8):3464.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"4458_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M Van de Wetering","year":"2015","unstructured":"Van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015 May 7;161(4):933-45.","journal-title":"Cell"},{"issue":"3","key":"4458_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/gbe\/evz033","volume":"11","author":"S-S Jo","year":"2019","unstructured":"Jo S-S, Choi SS. Analysis of the functional relevance of epigenetic chromatin marks in the first intron associated with specific gene expression patterns. Genome Biol Evol. 2019;11(3):786\u201397.","journal-title":"Genome Biol Evol"},{"issue":"3","key":"4458_CR39","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ac57a6","volume":"14","author":"W Pi","year":"2022","unstructured":"Pi W, Zhang Y, Li L, Li C, Zhang M, Zhang W et al. Polydopamine-coated polycaprolactone\/carbon nanotube fibrous scaffolds loaded with brain-derived neurotrophic factor for peripheral nerve regeneration. Biofabrication. 2022 Jul 1;14(3):035006.","journal-title":"Biofabrication"},{"issue":"7","key":"4458_CR40","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018 Dec 13;175(7):1972-88.","journal-title":"Cell"},{"key":"4458_CR41","doi-asserted-by":"crossref","unstructured":"Kim B, Lee E. Cryopreservation of engineered tissues and organoids. Organoid 2023; 3","DOI":"10.51335\/organoid.2023.3.e15"},{"issue":"1","key":"4458_CR42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nature communications. 2020 Mar 11;11(1):1310.","journal-title":"Nat Commun"},{"issue":"1","key":"4458_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-cellbio-120320-035146","volume":"38","author":"R Keshara","year":"2022","unstructured":"Keshara R, Kim YH, Grapin-Botton A. Organoid imaging: seeing development and function. Annu Rev Cell Dev Biol. 2022;38(1):447\u201366.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6378","key":"4458_CR44","first-page":"920","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018 Feb 23;359(6378):920-6.","journal-title":"Science (1979)"},{"issue":"1","key":"4458_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","volume":"5","author":"GE Wensink","year":"2021","unstructured":"Wensink GE, Elias SG, Mullenders J, Koopman M, Boj SF, Kranenburg OW et al. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. NPJ precision oncology. 2021 Apr 12;5(1):30.","journal-title":"NPJ Precis Oncol"},{"key":"4458_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01260-z","author":"L Horvath","year":"2020","unstructured":"Horvath L, Thienpont B, Zhao L, Wolf D, Pircher A. Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC): Novel approaches and future outlook. BioMed Central Ltd. 2020. https:\/\/doi.org\/10.1186\/s12943-020-01260-z.","journal-title":"BioMed Central Ltd"},{"key":"4458_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.771173","volume":"11","author":"ER Spiller","year":"2021","unstructured":"Spiller ER, Ung N, Kim S, Patsch K, Lau R, Strelez C et al. Imaging-based machine learning analysis of patient-derived tumor organoid drug response. Frontiers in oncology. 2021 Dec 21;11:771173.","journal-title":"Front Oncol"},{"issue":"4","key":"4458_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","volume":"4","author":"A Herland","year":"2020","unstructured":"Herland A, Maoz BM, Das D, Somayaji MR, Prantil-Baun R, Novak R et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nature biomedical engineering. 2020 Apr;4(4):421-36.","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"4458_CR49","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2020.10.014","volume":"27","author":"D Hendriks","year":"2020","unstructured":"Hendriks D, Clevers H, Artegiani B. CRISPR-Cas tools and their application in genetic engineering of human stem cells and organoids. Cell Stem Cell. 2020;27(5):705\u201331.","journal-title":"Cell Stem Cell"},{"issue":"7785","key":"4458_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019 Dec 5;576(7785):149-57.","journal-title":"Nature"},{"issue":"1","key":"4458_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ueg2.12701","volume":"13","author":"AK Beutel","year":"2025","unstructured":"Beutel AK, Ekizce M, Ettrich TJ, Seufferlein T, Lindenmayer J, Gout J et al. Organoid\u2010based precision medicine in pancreatic cancer. United European Gastroenterology Journal. 2025 Feb;13(1):21-33.","journal-title":"United European Gastroenterol J"},{"issue":"11","key":"4458_CR52","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/cells14110829","volume":"14","author":"A Jabri","year":"2025","unstructured":"Jabri A, Alsharif M, Abbad T, Taftafa B, Mhannayeh A, Elsalti A et al. Endometrial organoids and their role in modeling human infertility. Cells. 2025 Jun 3;14(11):829.","journal-title":"Cells"},{"key":"4458_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.661472","volume":"9","author":"R Heremans","year":"2021","unstructured":"Heremans R, Jan Z, Timmerman D, Vankelecom H. Organoids of the female reproductive tract: innovative tools to study desired to unwelcome processes. Front Cell Dev Biol. 2021;9:661472.","journal-title":"Front Cell Dev Biol"},{"key":"4458_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102832","volume":"78","author":"J Chakraborty","year":"2022","unstructured":"Chakraborty J, Chawla S, Ghosh S. Developmental biology-inspired tissue engineering by combining organoids and 3D bioprinting. Curr Opin Biotechnol. 2022;78:102832.","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"4458_CR55","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/cancers14041069","volume":"14","author":"S Furbo","year":"2022","unstructured":"Furbo S, Urbano PCM, Raskov HH, Troelsen JT, Kanstrup Fiehn A-M, G\u00f6genur I. Use of patient-derived organoids as a treatment selection model for colorectal cancer: a narrative review. Cancers (Basel). 2022;14(4):1069.","journal-title":"Cancers (Basel)"},{"key":"4458_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.celrep.2020.107762","volume":"31","author":"CJ de Witte","year":"2020","unstructured":"De Witte CJ, Valle-Inclan JE, Hami N, L\u00f5hmussaar K, Kopper O, Vreuls CP et al. Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter-and intrapatient drug responses. Cell reports. 2020 Jun 16;31(11).","journal-title":"Cell Rep"},{"issue":"5","key":"4458_CR57","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/biolre\/ioaa124","volume":"103","author":"Z-Y Gu","year":"2020","unstructured":"Gu Z-Y, Jia S-Z, Liu S, Leng J-H. Endometrial organoids: a new model for the research of endometrial-related diseases. Biol Reprod. 2020;103(5):918\u201326.","journal-title":"Biol Reprod"},{"issue":"12","key":"4458_CR58","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/jpm11121314","volume":"11","author":"CE Filby","year":"2021","unstructured":"Filby CE, Wyatt KA, Mortlock S, Cousins FL, McKinnon B, Tyson KE et al. Comparison of organoids from menstrual fluid and hormone-treated endometrium: novel tools for gynecological research. Journal of Personalized Medicine. 2021 Dec 6;11(12):1314.","journal-title":"J Pers Med"},{"issue":"9","key":"4458_CR59","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","volume":"39","author":"V Veninga","year":"2021","unstructured":"Veninga V, Voest EE. Tumor organoids: opportunities and challenges to guide precision medicine. Cancer Cell. 2021;39(9):1190\u2013201.","journal-title":"Cancer Cell"},{"issue":"1","key":"4458_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40661-016-0027-4","volume":"3","author":"M Glasgow","year":"2016","unstructured":"Glasgow M, Vogel RI, Burgart J, Argenta P, Dusenbery K, Geller MA. Long term follow-up of a phase II trial of multimodal therapy given in a \u2018sandwich\u2019 method for stage III, IV, and recurrent endometrial cancer. Gynecol Oncol Res Pract. 2016;3(1):6.","journal-title":"Gynecol Oncol Res Pract"},{"issue":"3","key":"4458_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.835","volume":"116","author":"E Ju\u00e1rez-Barber","year":"2021","unstructured":"Ju\u00e1rez-Barber E, Corach\u00e1n A, Franc\u00e9s-Herrero E, Faus A, Pellicer A, Cervell\u00f3 I et al. DEVELOPMENT OF SECRETOR AND GESTATIONAL PATIENT-DERIVED ORGANOIDS FROM ADENOMYOSIS DISEASE AS AN IN VITRO MODEL TO STUDY ADENOMYOSIS-RELATED INFERTILITY AND PERSONALIZED DRUG SCREENING. Fertility and Sterility. 2021 Sep 1;116(3):e310.","journal-title":"Fertil Steril"},{"issue":"4","key":"4458_CR62","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","volume":"14","author":"N Maenhoudt","year":"2020","unstructured":"Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Reports. 2020 Apr 14;14(4):717-29.","journal-title":"Stem Cell Reports"},{"key":"4458_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.762184","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Cong L, Cong X. Patient-derived organoids in precision medicine: drug screening, organoid-on-a-chip and living organoid biobank. Front Oncol. 2021;11:762184.","journal-title":"Front Oncol"},{"issue":"7","key":"4458_CR64","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.039347","volume":"12","author":"MA Lancaster","year":"2019","unstructured":"Lancaster MA, Huch M. Disease modelling in human organoids. Dis Model Mech. 2019;12(7):dmm039347.","journal-title":"Dis Model Mech"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04458-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04458-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04458-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:02:12Z","timestamp":1782590532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04458-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":64,"alternative-id":["4458"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04458-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study needs no approval or a statement of local ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}